Research facility
Hypertension pulmonaire : physiopathologie et innovation thérapeutique
Le Plessis-Robinson, France · u999.universite-paris-saclay.fr
Part of Inserm
- Citations, last 5 years
- 9 879
- Works, last 5 years
- 461
- h-index
- 159
- Scientists listed
- 0
- Grants since 2016
- 6
Grants received
2026 · research · AAPG2025
Role of Transcription Factor TBX4 in Pulmonary Arterial Hypertension
Gregoire Ruffenach · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
2023 · research · AAPG2023
Involvement of red blood cells and free hemoglobin in AKI in severe trauma
Anatole Harrois · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
2021 · research · AAPG2020
To capitalize on activated adventitial fibroblasts metabolism to treat pulmonary hypertension
Frédéric Perros · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
2019 · research · AAPG2018
Impact of LUng MIcrobiota in vascular remodeling and pulmonary arterial hypertension: potential for innovative biotherapeutic target
Sylvia Cohen-Kaminsky · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
2018 · research · AAPG2018
KCNK3 channel A new therapeutic target in Pulmonary Arterial Hypertension
Fabrice Antigny · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
2017 · research · AAPG2017
Contribution of the Vascular Smooth Muscle Cell-associated Type I cytokine receptors to Pulmonary Arterial Hypertension: At the interface between inflammation and pulmonary vascular remodeling
Alice Huertas · Hypertension pulmonaire : physiopathologie et innovation thérapeutique · funded by Agence Nationale de la Recherche
